Printer Icon

Pharmaceuticals Will Roll Back Price on Daraprim

By Human Rights Campaign (HRC) - 2015-11-26

Summary

Turing Pharmaceuticals came under intense scrutiny after the outrageous price hike made headlines.

"According to news reports overnight, Shkreli's Turing Pharmaceuticals now plans to drop the cost of the lifesaving drug by "as much as 50 percent" which is still more than $375 – far above the drug's original $13.50 price."

Main Document

The Human Rights Campaign (HRC), the nation’s largest lesbian, gay, bisexual, and transgender (LGBT) civil rights organization, slammed Turing Pharmaceuticals for announcing they will continue their outrageous price hike on Daraprim – a crucial and often lifesaving treatment for people living with HIV. Public outrage followed Shkreli's reckless decision to raise the price of Daraprim by 5,000 percent overnight back in September. According to news reports overnight, Shkreli's Turing Pharmaceuticals now plans to drop the cost of the lifesaving drug by "as much as 50 percent" which is still more than $375 – far above the drug's original $13.50 price.

HRC President Chad Griffin said:

“Martin Shkreli is not pulling the wool over anyone's eyes. After increasing the price of Daraprim by 5,000 percent, he now proposes to gouge critically ill people upwards of $375 for a drug that used to cost just a few dollars. His desire to turn a profit at any cost and brazen disregard for the well-being of the most vulnerable patients – including people with HIV and pregnant women – is appalling and contemptible. We continue to call on Congress, the Administration and the New York Attorney General to hold Turing Pharmaceuticals to account and do what is necessary to restore this life-saving treatment to its original price.”

Turing Pharmaceuticals came under intense scrutiny after the outrageous price hike made headlines. HRC joined 151 other organizations from across the nation in signing an open letter to Turing Pharmaceuticals urging company CEO Martin Shkreli to act. Prior to that, at HRC’s urging, New York Attorney General Eric Schneiderman began investigating whether Turing Pharmaceuticals may have violated antitrust laws by limiting distribution of a drug that is essential to the lives of medically vulnerable people.

HRC also sent letters to;

Sen. Lamar Alexander (R-TN), Chair of the Committee on Health, Education, Labor and Pensions

Rep. Fred Upton (R-MI), Chair of the Committee on Energy and Commerce

Rep. Jason Chaffetz (R-UT), Chair of the Committee on Oversight and Government Reform

seeking an investigation into the unconscionable action of Turing Pharmaceuticals.

The letters also called for an inquiry into Turing’s acquisition of Daraprim, the pricing strategy for the drug, investments made to bring the drug to market, the impact of that strategy on patient access, and the increased cost to federally-funded health programs. And they requested a hearing on formulary and tiering structure for prescription medications offered through health exchanges.

The Human Rights Campaign is America’s largest civil rights organization working to achieve lesbian, gay, bisexual and transgender equality. HRC envisions a world where LGBT people are embraced as full members of society at home, at work and in every community.

Comments and Discussions

Do you agree, disagree, or want to add an opinion on this topic? We welcome relevant discussions and your unique insights.

Related Information on This Topic

Cite This Document

2017 Hong Kong LGBT+ Inclusion Index and Awards - Community Business announces launch of 2017 LGBT+ Inclusion Index and Awards at the LGBT+ Networking Reception as part of the regional Community Business Conference


LGBT Conversion Therapy Quacks - Federal consumer fraud complaint against organization using claims that it can change an individuals sexual orientation or gender identity


OutWOMEN Initiative for Senior LGBT Women in Business - Launch of OutWOMEN, an initiative that champions success of senior LGBT women in business


Gallup Survey Shows Over 10 Million American Adults Identify as LGBTQ - New Gallup survey reveals increase in United States adults identifying as LGBTQ - 10 million, or 4.1% of the population, compared to 8.3M 4 years ago


GLAAD Launches Trump Accountability Project - Trump Accountability Project (TAP) is a resource for news makers reporting on the Trump administration which catalogues anti-LGBTQ statements and actions of Donald Trump and those in or being considered for his administration


F*ck Without Fear Campaign to Reduce HIV Infection Rate by Promoting PrEP - F*ck W/Out Fear is the message of new Los Angeles LGBT Center Campaign to reduce HIV infection rate by promoting PrEP